ELSOFT RESEARCH BERHAD (0090.KL)
- Sector
- Technology
- Price
- RM 0.285 (-1.72%)
- Market cap
- 192.7M MYR
See analyst ratings, target prices and the track record of every expert covering ELSOFT RESEARCH BERHAD. Unlock full analyst calls.
About ELSOFT RESEARCH BERHAD
Company Description
Elsoft Research Berhad is a Malaysia-based technology company listed on the Main Market of Bursa Malaysia, operating within the automated test equipment industry. The company designs and manufactures test solutions, with core operations spanning conventional test equipment, new automated test equipment, and medical devices. It primarily serves end markets such as automotive, general lighting, smart devices, and medical sectors. Additionally, the group is diversifying into metalens test solutions to broaden its future growth prospects and reduce reliance on traditional semiconductor markets.
Business Model
Elsoft generates revenue by designing, developing, and selling automated test equipment and medical devices to manufacturers. Its operational structure is organized around its core product segments: conventional test equipment, new automated test equipment, and medical devices. The company's key advantages include a solid balance sheet characterized by zero debt and a significant net cash position, which provides financial resilience during cyclical downturns. Furthermore, Elsoft employs a diversification strategy, expanding into the medical devices segment and metalens test solutions to create new revenue streams and mitigate the cyclicality of the semiconductor test equipment market.
Revenue Segment
The reports do not provide percentage breakdowns. Revenue is generated from the conventional test equipment, new automated test equipment, and medical devices segments. In FY2025, the medical devices segment emerged as the key earnings driver, supported by an outstanding order book of approximately RM10mn, while the automated test equipment segments for automotive, general lighting, and smart devices experienced subdued demand.
Operational Scale
The reports do not quantify operational scale metrics such as the number of facilities or production units. However, for the most recent historical year, the company reported an outstanding order book of approximately RM10mn for its medical devices segment scheduled for delivery in 2026. Additionally, Elsoft maintained a substantial financial scale with a net cash position of RM83.5mn or 12.0 sen per share as of end-FY2025.